Cranial and related sensorimotor impairments in rodent models of Parkinson's disease

Behavioural Brain Research

Volumn 231, Issue 2, 2012, Pages 317-322

  Fleming, Sheila M ^a   Schallert, Tim ^b   Ciucci, Michelle R ^c  

^a UNIVERSITY OF CINCINNATI   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Animal models; Behavioral tests; Parkinson's disease

Indexed keywords

BODY MOVEMENT; DISEASE MODEL; GENETIC MODEL; LIMB MOVEMENT; NEGLECT; NEUROMUSCULAR DISEASE; NONHUMAN; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; REVIEW; RODENT; SENSORIMOTOR FUNCTION; SENSORIMOTOR IMPAIRMENT; SENSORY STIMULATION; SOMATOSENSORY SYSTEM; STIMULUS RESPONSE; SWALLOWING; VOCALIZATION;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; BRAIN CHEMISTRY; DISEASE MODELS, ANIMAL; FEEDING BEHAVIOR; MICE; MOTOR ACTIVITY; MOVEMENT; MOVEMENT DISORDERS; MPTP POISONING; NESTING BEHAVIOR; OXIDOPAMINE; PARKINSON DISEASE, SECONDARY; POSTURAL BALANCE; PSYCHOMOTOR PERFORMANCE; RATS; SENSATION DISORDERS; SYMPATHOLYTICS; VOCALIZATION, ANIMAL;

EID: 84860841292     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2012.02.034     Document Type: Review

References (83)

1. Marshall J.F., Richardson J.S., Teitelbaum P. Nigrostriatal bundle damage and the lateral hypothalamic syndrome. J Comp Physiol Psychol 1974, 87:808-830.
2. Schallert T., Whishaw I.Q., Ramirez V.D., Teitelbaum P. Compulsive, abnormal walking caused by anticholinergics in akinetic, 6-hydroxydopamine-treated rats. Science 1978, 199:1461-1463.
3. Carlsson A., Lindqvist M., Magnusson T. 3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists. Nature 1957, 180(4596):1200.
4. Ungerstedt U. Adipsia and aphagia after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol Scand Suppl 1971, 367:95-122.
5. Burns R.S., Chiueh C.C., Markey S.P., Ebert M.H., Jacobowitz D.M., Kopin I.J. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci USA 1983, 80(14):4546-4550.
6. Betarbet R., Sherer T.B., MacKenzie G., Garcia-Osuna M., Panov A.V., Greenamyre J.T. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 2000, 3(12):1301-1306.
7. Brooks A.I., Chadwick C.A., Gelbard H.A., Cory-Slechta D.A., Federoff H.J. Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss. Brain Res 1999, 823(1-2):1-10.
8. Fleming S.M., Salcedo J., Fernagut P.O., Rockenstein E., Masliah E., Levine M.S., et al. Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein. J Neurosci 2004, 24(42):9434-9440.
9. Fleming S.M., Delville Y., Schallert T. An intermittent, controlled-rate, slow progressive degeneration model of Parkinson's disease: antiparkinson effects of Sinemet and protective effects of methylphenidate. Behav Brain Res 2005, 156(2):201-213.
10. Tillerson J.L., Caudle W.M., Reveron M.E., Miller G.W. Detection of behavioral impairments correlated to neurochemical deficits in mice treated with moderate doses of 1 methyl-4-phenyl 1,2,3,6-tetrahydropyridine. Exp Neurol 2002, 178:80-90.
11. Alam M., Schmidt W.J. l-DOPA reverses the hypokinetic behaviour and rigidity in rotenone-treated rats. Behav Brain Res 2004, 153(2):439-446.
12. Ciucci M.R., Ma S.T., Fox C., Kane J.R., Ramig L.O., Schallert T. Qualitative changes in ultrasonic vocalization in rats after unilateral dopamine depletion or haloperidol: a preliminary study. Behav Brain Res 2007, 182:284-289.
13. Ciucci M.R., Ma S.T., Kane J.R., Ahrens A.M., Schallert T. Limb use and complex ultrasonic vocalization in a rat model of Parkinson's disease: deficit-targeted training. Parkinsonism Relat Disord 2008, 14(Suppl 2):S172-S175.
14. Ciucci M.R., Connor N.P. Dopaminergic influence on rat tongue function and limb movement initiation. Exp Brain Res 2009, 194:587-596.
15. Ciucci M.R., Russell J.A., Schaser A.J., Doll E.J., Vinney L.M., Connor N.P. Tongue force and timing deficits in a rat model of Parkinson disease. Behav Brain Res 2011, 222(2):315-322.
16. Masliah E., Rockenstein E., Veinbergs I., Mallory M., Hashimoto M., Takeda A., et al. Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science 2000, 287(5456):1265-1269.
17. Rockenstein E., Mallory M., Hashimoto M., Song D., Shults C.W., Lang I., et al. Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters. J Neurosci Res 2002, 68:568-578.
18. Goldberg M.S., Fleming S.M., Palacino J.J., Cepeda C., Lam H.A., Bhatnagar A., et al. Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. J Biol Chem 2003, 278(44):43628-43635.
19. Chen L., Cagniard B., Mathews T., Jones S., Koh H.C., Ding Y., et al. Age-dependent motor deficits and dopaminergic dysfunction in DJ-1 null mice. J Biol Chem 2005, 280(22):21418-21426.
20. Li Y., Liu W., Oo T.F., Wang L., Tang Y., Jackson-Lewis V., et al. Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease. Nat Neurosci 2009, 12(7):826-828.
21. Kirik D., Rosenblad C., Burger C., Lundberg C., Johansen T.E., Muzyczka N., et al. Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system. J Neurosci 2002, 22(7):2780-2791.
22. Yang M., Stull N.D., Berk M.A., Snyder E.Y., Iacovitti L. Neural stem cells spontaneously express dopaminergic traits after transplantation into the intact or 6-hydroxydopamine-lesioned rat. Exp Neurol 2002, 177(1):50-60.
23. Kozlowski D.A., Connor B., Tillerson J.L., Schallert T., Bohn M.C. Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections. Exp Neurol 2000, 166(1):1-15.
24. Connor B., Kozlowski D.A., Schallert T., Tillerson J.L., Davidson B.L., Bohn M.C. Differential effects of glial cell line-derived neurotrophic factor (GDNF) in the striatum and substantia nigra of the aged parkinsonian rat. Gene Ther 1999, 6(12):1936-1951.
25. Luo J., Kaplitt M.G., Fitzsimons H.L., Zuzga D.S., Liu Y., Oshinsky M.L., et al. Subthalamic GAD gene therapy in a Parkinson's disease rat model. Science 2002, 298(5592):425-429.
26. Schallert T., Norton D., Jones T.A. A clinically relevant unilateral rat model of parkinsonian akinesia. J Neural Transplant Plast 1992, 3:332-333.
27. Schallert T., Fleming S.M., Leasure J.L., Tillerson J.L., Bland S.T. CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology 2000, 39(5):777-787.
28. Olsson M., Nikkhah G., Bentlage C., Björklund A. Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test. J Neurosci 1995, 15(5 Pt 2):3863-3875.
29. Lindner M.D., Plone M.A., Francis J.M., Emerich D.F. Validation of a rodent model of Parkinson's disease: evidence of a therapeutic window for oral Sinemet. Brain Res Bull 1996, 39(6):367-372.
30. Tillerson J.L., Cohen A.D., Philhower J., Miller G.W., Zigmond M.J., Schallert T. Forced limb-use effects on the behavioral and neurochemical effects of 6-hydroxydopamine. J Neurosci 2001, 21(12):4427-4435.
31. Tillerson J.L., Cohen A.D., Caudle W.M., Zigmond M.J., Schallert T., Miller G.W. Forced nonuse in unilateral parkinsonian rats exacerbates injury. J Neurosci 2002, 22(15):6790-6799.
32. Chang J.W., Wachtel S.R., Young D., Kang U.J. Biochemical and anatomical characterization of forepaw adjusting steps in rat models of Parkinson's disease: studies on medial forebrain bundle and striatal lesions. Neuroscience 1999, 88(2):617-628.
33. Schallert T., Tillerson J.L. Intervention strategies for degeneration of dopamine neurons in parkinsonism: optimizing behavioral assessment of outcome. Central nervous system diseases 2000, 131-151. Humana Press, Totowa, NJ. D.F. Emerich, R.L. Dean, P.R. Sandberg (Eds.).
34. Fleming S.M., Zhu C., Fernagut P.O., Mehta A., DiCarlo C.D., Seaman R.L., et al. Behavioral and immunohistochemical effects of chronic intravenous and subcutaneous infusions of varying doses of rotenone. Exp Neurol 2004, 187(2):418-422.
35. Schallert T., De Ryck M., Whishaw I.Q., Ramirez V.D., Teitelbaum P. Excessive bracing reactions and their control by atropine and l-DOPA in an animal analog of parkinsonism. Exp Neurol 1979, 64:33-43.
36. Schallert T., Upchurch M., Lobaugh N., Farrar S.B., Spirduso W.W., Gilliam P., et al. Tactile extinction: distinguishing between sensorimotor and motor asymmetries in rats with unilateral nigrostriatal damage. Pharmacol Biochem Behav 1982, 16(3):455-462.
37. Schallert T., Upchurch M., Wilcox R.E., Vaughn D.M. Posture-independent sensorimotor analysis of inter-hemispheric receptor asymmetries in neostriatum. Pharmacol Biochem Behav 1983, 18(5):753-759.
38. Klein A., Sacrey L.A., Whishaw I.Q., Dunnett S.B. The use of rodent skilled reaching as a translational model for investigating brain damage and disease. Neurosci Biobehav Rev 2011, 36(3):1030-1042.
39. Miklyaeva E.I., Castañeda E., Whishaw I.Q. Skilled reaching deficits in unilateral dopamine-depleted rats: impairments in movement and posture and compensatory adjustments. J Neurosci 1994, 14(11 Pt 2):7148-7158.
40. Abrous D.N., Wareham A.T., Torres E.M., Dunnett S.B. Unilateral dopamine lesions in neonatal, weanling and adult rats: comparison of rotation and reaching deficits. Behav Brain Res 1992, 51(1):67-75.
41. Whishaw I.Q., Suchowersky O., Davis L., Sarna J., Metz G.A., Pellis S.M. Impairment of pronation, supination, and body co-ordination in reach-to-grasp tasks in human Parkinson's disease (PD) reveals homology to deficits in animal models. Behav Brain Res 2002, 133(2):165-176.
42. Metz G.A., Whishaw I.Q. The ladder rung walking task: a scoring system and its practical application. J Vis Exp 2009, 28:1204. 10.3791/1204.
43. Faraji J., Metz G.A. Sequential bilateral striatal lesions have additive effects on single skilled limb use in rats. Behav Brain Res 2007, 177(2):195-204.
44. Metz G.A., Whishaw I.Q. Cortical and subcortical lesions impair skilled walking in the ladder rung walking test: a new task to evaluate fore- and hindlimb stepping, placing, and co-ordination. J Neurosci Methods 2002, 115(2):169-179.
45. Glajch KE, Fleming SM, Surmeier DJ, Osten P, Sensorimotor assessment of the unilateral 6-hydroxydopamine mouse model of Parkinson's disease. Behav Brain Res 2011 Dec 9 [Epub ahead of print], . doi:10.1016/j.bbr.2011.12.007.
46. Hwang D.Y., Fleming S.M., Ardayfio P., Moran-Gates T., Kim H., Tarazi F.I., et al. 3,4-dihydroxyphenylalanine reverses the motor deficits in Pitx3-deficient aphakia mice: behavioral characterization of a novel genetic model of Parkinson's disease. J Neurosci 2005, 25(8):2132-2137.
47. Lu X.H., Fleming S.M., Meurers B., Ackerson L.C., Mortazavi F., Lo V., et al. Bacterial artificial chromosome transgenic mice expressing a truncated mutant parkin exhibit age-dependent hypokinetic motor deficits, dopaminergic neuron degeneration, and accumulation of proteinase K-resistant alpha-synuclein. J Neurosci 2009, 29(7):1962-1967.
48. Tillerson J.L., Caudle W.M., Reveron M.E., Miller G.W. Detection of behavioral impairments correlated to neurochemical deficits in mice treated with moderate doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Exp Neurol 2002, 178(1):80-90.
49. Hofele K., Sedelis M., Auburger G.W., Morgan S., Huston J.P., Schwarting R.K. Evidence for a dissociation between MPTP toxicity and tyrosinase activity based on congenic mouse strain susceptibility. Exp Neurol 2001, 168(1):116-122.
50. Sedelis M., Hofele K., Auburger G.W., Morgan S., Huston J.P., Schwarting R.K. MPTP susceptibility in the mouse: behavioral, neurochemical, and histological analysis of gender and strain differences. Behav Genet 2000, 30(3):171-182.
51. Szczypka M.S., Kwok K., Brot M.D., Marck B.T., Matsumoto A.M., Donahue B.A., et al. Dopamine production in the caudate putamen restores feeding in dopamine-deficient mice. Neuron 2001, 30(3):819-828.
52. Upchurch M., Schallert T. A behavior analysis of the offspring of haloperidol-sensitive and haloperidol-resistant gerbils. Behav Neural Biol 1983, 39(2):221-228.
53. Plowman-Prine E.K., Sapienza C.M., Okun M.S., Pollock S.L., Jacobson C., Wu S.S., et al. The relationship between quality of life and swallowing in Parkinson's disease. Mov Disord 2009, 24:1352-1358.
54. Miller N., Noble E., Jones D., Burn D. Hard to swallow: dysphagia in Parkinson's disease. Age Ageing 2006, 35:614-618.
55. Marras C., McDermott M.P., Rochon P.A., Tanner C.M., Naglie G., Lang A.E. Predictors of deterioration in health-related quality of life in Parkinson's disease: results from the DATATOP trial. Mov Disord 2008, 23:653-659. quiz 776.
56. Darley F.L., Aronson A.E., Brown J.R. Clusters of deviant speech dimensions in the dysarthrias. J Speech Hear Res 1969, 12:462-496.
57. Ho A.K., Iansek R., Marigliani C., Bradshaw J.L., Gates S. Speech impairment in a large sample of patients with Parkinson's disease. Behav Neurol 1998, 11:131-137.
58. Sapir S., Ramig L., Fox C. Speech and swallowing disorders in Parkinson disease. Curr Opin Otolaryngol Head Neck Surg 2008, 16:205-210.
59. Michou E., Hamdy S. Dysphagia in Parkinson's disease: a therapeutic challenge. Expert Rev Neurotherapeutics 2010, 10:875-878.
60. Fuh J.L., Lee R.C., Wang S.J., Lin C.H., Wang P.N., Chiang J.H., et al. Swallowing difficulty in Parkinson's disease. Clin Neurol Neurosurg 1997, 99:106-112.
61. Monte F.S., da Silva-Júnior F.P., Braga-Neto P., Nobre e Souza M.A., de Bruin V.M. Swallowing abnormalities and dyskinesia in Parkinson's disease. Mov Disord 2005, 20:457-462.
62. Leopold N.A., Kagel M.C. Pharyngo-esophageal dysphagia in Parkinson's disease. Dysphagia 1997, 12:18.
63. Brudzynski S.M. Principles of rat communication: quantitative parameters of ultrasonic calls in rats. Behav Genet 2005, 35:85-92.
64. Brudzynski S.M., Pniak A. Social contacts and production of 50kHz short ultrasonic calls in adult rats. J Compar Psychol 2002, 116:73-82.
65. Wöhr M., Houx B., Schwarting R.K., Spruijt B. Effects of experience and context on 50kHz vocalizations in rats. Physiol Behav 2008, 93:766-776.
66. Bialy M., Rydz M., Kaczmarek L. Precontact 50kHz vocalizations in male rats during acquisition of sexual experience. Behav Neurosci 2000, 114:983-990.
67. Burgdorf J., Wood P.L., Kroes R.A., Moskal J.R., Panksepp J. Neurobiology of 50kHz ultrasonic vocalizations in rats: electrode mapping, lesion, and pharmacology studies. Behav Brain Res 2007, 182:274-283.
68. McGinnis M.Y., Vakulenko M. Characterization of 50kHz ultrasonic vocalizations in male and female rats. Physiol Behav 2003, 80:81-88.
69. Riede T. Subglottal pressure, tracheal airflow, and intrinsic laryngeal muscle activity during rat ultrasound vocalization. J Neurophysiol 2011, 106:2580-2592.
70. Johnson A.M., Ciucci M.R., Russell J.A., Hammer M.J., Connor N.P. Ultrasonic output from the excised rat larynx. J Acoust Soc Am 2010, 128:EL75-EL79.
71. Ciucci M.R., Ahrens A.M., Ma S.T., Kane J.R., Windham E.B., Woodlee M.T., et al. Reduction of dopamine synaptic activity: Degradation of 50-kHz ultrasonic vocalization in rats. Behav Neurosci 2009, 123:328-336.
72. Kane J.R., Ciucci M.R., Jacobs A.N., Tews N., Russell J.A., Ahrens A.M., et al. Assessing the role of dopamine in limb and cranial-oromotor control in a rat model of Parkinson's disease. J Commun Disord 2011, 44:529-537.
73. Fowler S.C., Mortell C. Low doses of haloperidol interfere with rat tongue extensions during licking: a quantitative analysis. Behav Neurosci 1992, 106:386-395.
74. Stanford J.A., Vorontsova E., Surgener S.P., Gerhardt G.A., Fowler S.C. Aged Fischer 344 rats exhibit altered orolingual motor function: relationships with nigrostriatal neurochemical measures. Neurobiol Aging 2003, 24:259-266.
75. Smittkamp S.E., Brown J.W., Stanford J.A. Time-course and characterization of orolingual motor deficits in B6SJL-Tg(SOD1-G93A)1Gur/J mice. Neurosci 2008, 151:613-621.
76. Connor N.P., Russell J.A., Wang H., Jackson M.A., Mann L., Kluender K. Effect of tongue exercise on protrusive force and muscle fiber area in aging rats. J Speech Lang Hear Res 2009, 52:732-744.
77. Ciucci M.R., Russell J.A., Schaser A.M., Doll E.J., Vinney L., Connor N.P. Tongue force and timing deficits in a rat model of Parkinson disease. Behav Brain Res 2011, 222(2):315-320.
78. Lever T.E., Simon E., Cox K.T., Capra N.F., O'Brien K.F., Hough M.S., et al. A mouse model of pharyngeal dysphagia in amyotrophic lateral sclerosis. Dysphagia 2010, 25(2):112-126.
79. Lever T.E., Gorsek A., Cox K.T., O'Brien K.F., Capra N.F., Hough M.S., et al. An animal model of oral dysphagia in amyotrophic lateral sclerosis. Dysphagia 2009, 24(2):180-195.
80. Allred R.P., Adkins D.L., Woodlee M.T., Husbands L.C., Maldonado M.A., Kane J.R., et al. The vermicelli handling test: a simple quantitative measure of dexterous forepaw function in rats. J Neurosci Methods 2008, 170:229-244.
81. Khaing Z.Z., Geissler S.A., Jiang S., Milman B.D., Aguilar S.V., Schmidt C.E., et al. Assessing forelimb function after unilateral cervical spinal cord injury: novel forelimb tasks predict lesion severity and recovery. J Neurotrauma 2012, 29(3):488-498.
82. Whishaw I.Q., Schallert T., Kolb B. An analysis of feeding and sensorimotor abilities of rats after decortication. J Comp Physiol Psychol 1981, 95:85-103.
83. Gonzalez C.L., Kolb B. A comparison of different models of stroke on behaviour and brain morphology. Eur J Neurosci 2003, 18:1950-1962.